Background
Israel’s national health-insurance system requires health funds to provide child-development diagnoses and treatments, including medicine, psychology, physical therapy, occupational therapy, social work, and communication-disorder services. Because the health funds repeatedly exceeded prescribed waiting periods, a 2010 directive allowed patients to obtain private treatment and receive reimbursement, less a copayment. Over time, that route came to account for roughly one-third of child-development treatments.
The Ministry of Health concluded that the reimbursement route, despite shortening some waits, increased inequality, drew professionals away from the public system, fragmented multidisciplinary care, and reduced incentives for health funds to improve their services. A reform therefore combined additional funding, salary increases, workforce expansion, and other measures with a five-stage phaseout of reimbursements. The phaseout began with specified groups of new patients in February 2026 and is scheduled to reach existing patients and certain diagnoses no earlier than January 2030, with later stages subject to professional review.
Two nonprofit organizations petitioned to freeze the reform for one year, compel disclosure of information concerning implementation readiness, and preserve reimbursements for patients already receiving private treatment. They alleged inadequate staffing and appointment availability, threats to continuity of care, increased socioeconomic inequality, and insufficient data about the health funds’ preparedness. The Ministry and health funds responded that the reform was carefully phased, professionally supported, and necessary to strengthen public care.
The Court’s Holding
The Supreme Court, sitting as the High Court of Justice, unanimously dismissed the petition. Justice Ruth Ronnen explained that management of the health system involves professional, budgetary, and socioeconomic policy judgments within the Ministry’s core expertise, so judicial intervention is limited. The decision to phase out reimbursements rested on professional considerations directed toward strengthening the public system, and the petitioners established no basis for the Court to substitute its judgment for that of the regulator.
The Court emphasized that the reform proceeds gradually and that advancement beyond its early stages depends on professional assessment and factual monitoring. The Ministry had already postponed the second-stage change for residents of designated remote communities after reviewing readiness. Existing patients may continue using reimbursements until the fifth stage, scheduled no earlier than January 1, 2030, providing a transition period that addressed the continuity-of-care concern.
The request for data also did not justify relief because the appropriate route for obtaining information from a public authority was an application under Israel’s Freedom of Information Law. The Court also criticized the petition’s numerous irrelevant or internally mismatched authorities, while declining to decide whether they resulted from improper use of artificial intelligence. It dismissed both the petition and an application by the Israeli Speech-Language-Hearing Association to participate as amicus curiae, and ordered the petitioners to pay each respondent NIS 4,000 in costs.
Key Takeaways
- Israeli courts apply substantial restraint when reviewing health-policy reforms grounded in professional, budgetary, and socioeconomic judgments.
- The Court upheld the reimbursement phaseout because it was gradual, monitored, subject to professional review, and accompanied by measures intended to expand public child-development services.
- Requests for government-held implementation data ordinarily should proceed under the Freedom of Information Law rather than through a direct High Court petition.
Why It Matters
The ruling permits Israel’s Ministry of Health to continue shifting child-development treatment from privately reimbursed care to services supplied directly by health funds and contracted providers. It also signals that challenges based on staffing shortages, waiting times, or possible future harm may not succeed while regulators are monitoring a phased reform and adapting its implementation.
The Court’s criticism of irrelevant and mismatched legal authorities is also a caution to lawyers using generative AI or automated research tools: counsel remain responsible for ensuring that every cited authority exists, is accurately characterized, and supports the proposition for which it is offered.